This article focuses on how GABA-ergic neurotransmitter systems may modulate the interaction between reproductive steroid and sex steroid systems, and sheds light on the role allopregnanolone may play in medicating vulnerability to depression.
Depression During Pregnancy Affect Infant’s Brain Anatomy, But No Change with Prenatal Exposure to SSRIs
Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.
Women may experience depression and post-traumatic symptoms, especially those who were separated from their newborns after delivery and those with severe COVID-19 illness during pregnancy or after delivery.
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
Depression During the COVID-19 Lockdown Highlights the Importance of Social Connections for New Moms
Because pregnant and postpartum women face unique challenges in the context of the COVID-19 pandemic, they may be at increased risk for mental health problems in this setting. In a recent study, researchers from the University College of London surveyed 162 new mothers in London between May and June 2020 using a social network survey designed to assess the impact of the COVID-19 lockdown.
There have been multiple studies over last year showing increased anxiety and depression in certain populations as a result of the COVID pandemic. It is clear that some members of the population may be [...]
In a given year, about 10% of mothers in the United States experience a major depressive episode (MDE). Roughly translated, this means about 1 in 10 children is exposed to maternal depression each year (Ertel [...]
Although we have data on the reproductive safety of various medications used to treat anxiety, many women would understandably prefer to avoid medications when possible. Many women ask about alternative treatments, including dietary supplements, herbal [...]
Women with bipolar disorder (BD) are at extremely high risk for postpartum psychiatric illness, including postpartum psychosis. While the American College of Obstetrics and Gynecology now recommends that all women be screened for depression [...]
Growing attention is being given to the public health dimensions of perinatal mood and anxiety disorders (PMADs). Previously, we have reviewed studies looking at the prevalence of screening for PMADs and disparities therein and [...]